# First-Pass Report — LUCID100 Wave 1 Slot 5

Paper: **Thaulow et al. 2020**, "Epigenetic, transcriptional and phenotypic responses in *Daphnia magna* exposed to low-level ionizing radiation." *Environmental Research* 190, 109930. DOI 10.1016/j.envres.2020.109930.

Subagent: Ollie. First pass: 2026-06-09 (CDT). Channel: Telegram via OpenClaw subagent.

## Verdict

**PARTIAL-SCOPE — figure-digitisation only.**

This paper is **not** an omics study in the LUCID100 master-TSV sense (its `worktype` was tagged "omics/signature replication"). It is a **targeted-assay phenotype + qPCR + ChIP-qPCR + LC-MS** study. There is **no public sequencing dataset, no supplementary file, no code repository, and no deposited per-individual measurement table.** The only quantitative-replication path that fits LUCID100's no-wet-lab / no-paid-endpoint / no-author-contact constraints is **manual figure digitisation** of Figs. 1, 2, 3, 6 and a PCA cross-check against the paper's reported PC1+PC2 = 85.41 % variance share.

The "ready-to-run" classification is **not** applicable. "No-go" overstates it — the paper is a perfectly valid science paper, it just doesn't ship the data needed for a true reproducibility audit. "Blocked" is also wrong, because nothing is gating us; the data simply does not exist publicly. "Partial-scope" is the honest verdict.

## Evidence

### Why not "ready-to-run"

- No `data availability` statement points to any external repository. Verified by `grep -niE 'GEO|GSE|SRA|SRP|PRJNA|PRJEB|ArrayExpress|E-MTAB|Dryad|Figshare|Zenodo|github|data availability|deposited|raw data'` on `artifacts/thaulow2020_envres.txt` (796 lines, full PDF). Matches are all incidental ("raw data" appears only in the §2.8 Statistical Analyses sentence "The raw data was checked for normality…", not as a deposit pointer).
- No Elsevier supplementary file (`MMC1..4` URL probe → HTTP 404 on `.pdf`, `.docx`, `.xlsx`).
- No "Appendix A. Supplementary data" section in the PDF body.

### Why not "blocked"

- Nothing is *failing* — the artifacts simply don't exist. There is no API error, login wall, or transient infrastructure problem. A re-fetch from a different network won't help.

### Why not "no-go"

- The PDF gives enough methodological detail (dose-rates, sample sizes, statistical tests, software versions, antibody catalog numbers, kit names) to reason about replication in principle. A wet-lab partner with a 60Co irradiator and Daphnia magna husbandry could reproduce the experiment from the paper alone (after lifting primer sequences from the three secondary citations). That's "out of LUCID100 scope", not "no-go in the strict sense."
- A cheap figure-digitisation pass *can* check the qualitative dose-response narrative and the PCA variance share. That's a real, scoped replication target.

### Why "partial-scope"

- Targeted, figure-level checks are feasible.
- Numeric exact-rerun and untargeted-omics replication are infeasible because the data is not public.

## What this slot will and will not produce

| Output kind                                          | This pass                  |
| ---------------------------------------------------- | -------------------------- |
| Exact numerical rerun of the paper's statistics     | ❌ Impossible — no raw data |
| Independent re-analysis of public omics             | ❌ Impossible — no omics deposited |
| Re-implementation of an analysis pipeline           | ❌ Nothing to re-implement — Prism+XLSTAT one-way ANOVA / Kruskal-Wallis / PCA |
| Figure-digitisation + qualitative dose-response check | ⚠️ Possible, deferred (cheap manual work, optional) |
| Acceptance-criteria-bearing PCA variance smoke test  | ✅ Harness written; needs digitised inputs to run |
| Artifact manifest + reproducibility scoping memo     | ✅ Produced in this pass    |
| README + PROGRESS + REPORT + JSON state              | ✅ All produced             |

## Recommendation to the LUCID100 maintainer

1. Update `lucid-replications/LUCID100_SOLID_MASTER_QA.tsv` row rank=36:
   - `worktype` → `targeted qPCR + ChIP-qPCR + LC-MS phenotype study` (not "omics/signature replication").
   - `qa_decision` annotation → "KEEP — figure-digitization scope only; no public data".
   - `verdict_or_plan` → "PARTIAL-SCOPE — figure-digitisation possible; numeric / omics replication infeasible (no deposited data)."
2. De-prioritise vs. other Wave-1 slots that *do* ship public omics; revisit only if a downstream LUCID consumer specifically needs a Daphnia-magna low-dose-rate qualitative reference.
3. Mark the slot complete for purposes of artifact harvest + scoping; leave figure-digitisation as a cheap optional follow-up.

## Compute footprint

- CherryRd local only. No heavy compute. No HPC job submitted. Total wall-clock for this first pass &lt; 5 minutes of CPU. The recommended optional follow-up (figure digitisation + PCA) is also CherryRd-trivial.

## Reproducibility of *this report*

- All harvested artifacts and the extracted text are under `artifacts/`. Sub-second to re-derive any quote with `grep` against `artifacts/thaulow2020_envres.txt`.
- Smoke test: `python3 repro/pca_variance_smoke.py` from this folder.
